NCT03869021 is a NA clinical trial of 3D printed surgical guide constructed in Hemifacial Microsomia, sponsored by Yasser Mohamed Nabil Ahmed Khirat El Hadidi.

Who is sponsoring NCT03869021?

NCT03869021 is sponsored by Yasser Mohamed Nabil Ahmed Khirat El Hadidi.

What drugs are being tested in NCT03869021?

Interventions in NCT03869021: 3D printed surgical guide constructed, free hand surgery.

What condition does NCT03869021 study?

NCT03869021 studies Hemifacial Microsomia.

Is NCT03869021 still recruiting?

NCT03869021 is currently completed. Last updated 11 March 2019.

Last reviewed 2019-03-11 · How we verify

NCT03869021

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Computer Guided for Mandibular Distraction Osteogenesis

Completed NA Last updated 11 March 2019

What this trial tests

NA trial testing 3D printed surgical guide constructed in Hemifacial Microsomia in 12 participants. Completed in 30 December 2018.

Timeline

30 December 2015

Primary endpoint
30 December 2018

30 December 2018

Quick facts

Lead sponsor	Yasser Mohamed Nabil Ahmed Khirat El Hadidi
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	12
Start date	30 December 2015
Primary completion	30 December 2018
Estimated completion	30 December 2018
Sites	1 location across Egypt

Drugs / interventions tested

3D printed surgical guide constructed
free hand surgery

Conditions studied

Hemifacial Microsomia — all drugs for Hemifacial Microsomia →

Sponsor

Yasser Mohamed Nabil Ahmed Khirat El Hadidi

Who can join

Adults 5 to 25, male only, with Hemifacial Microsomia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: Distraction Osteogenesis is an integral part in management of mandibular defects associated with Hemifacial Microsomia (HFM) and post-ankylotic mandibular defects. The most difficult part in distraction osteogenesis is the prediction of distraction vector and risk of injury to vital structures as inferior alveolar. The current study aimed to present Three-Dimensionally Constructed Computer Guided Splints in Distraction Osteogenesis to get an ideal vector and minimal risk of vital structures injury. Methods: The study presents computer-guided distraction osteogenesis surgery using prefabricated splints.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Yasser Mohamed Nabil Ahmed Khirat El Hadidi trials

Trials by the same sponsor.

NCT03861650 — Evaluation of Effect of Bone Marrow Aspirate Concentrate on Distracted Mandibular Bone Properties · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03869021 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yasser Mohamed Nabil Ahmed Khirat El Hadidi
Last refreshed: 11 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03869021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing